Meanwhile, RIP analysis showed that SLC16A1-AS1 was enriched on the anti-IGF2BP3 antibody, which was significantly inhibited after knockdown of METTL3 in HCC cells (Supplementary Fig. S5F). The gene discussed is SLC16A1; the disease is hepatocellular carcinoma.